Cipla Shares Drop 5% But Trim Losses After USFDA Issues Warning Letter to Goa Unit

The warning letter reportedly said that the pharma company may continue to sell existing drugs from the Goa facility, but newer approvals will be held if corrective measures are not taken.

from Top Business News- News18.com https://ift.tt/2T0t8Kr

No comments:

Post a Comment

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...